Submission for OMB Review; Comment Request, 5164-5165 [E9-1925]
Download as PDF
<![CDATA[
5164
Federal Register / Vol. 74, No. 18 / Thursday, January 29, 2009 / Notices
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN—Continued
Number of
respondents
Form Name
Total burden
hours
Average
hourly wage
rate*
Total cost
burden
Web site visitors survey ...................................................................................
150
30
30.33
910
Total ..........................................................................................................
166
125
na
3,791
* The average hourly wage rate of $30.33 was calculated based on the following mean hourly wage rates: pharmacists—$47.58; pharmacy
manager [medical & health services manager category]—$50.34; pharmacy tecimicians—$13.25; and pharmacy aides $10.15. The mean hourly
wage rates for these occupations were obtained from the Bureau of Labor & Statistics on ‘‘Occupational Employment and Wages, May 2007,’’
found at: http//www.bls.gov/OES/current/oes291051.htm.
Estimated Annual Costs to the
Government
extends over three fiscal years. Exhibit
3 shows a breakdown of the total cost
as well as the annualized cost.
The total cost of this contract to the
government is $400,000. The project
EXHIBIT 3
Cost component
Total cost
Annualized
cost
Project Development ...............................................................................................................................................
Data Collection Activities .........................................................................................................................................
Data Processing and Analysis .................................................................................................................................
Publication of Results ..............................................................................................................................................
Project Management ................................................................................................................................................
$54,822
111,509
129,089
63,736
40,845
$18,274
37,170
43,030
21,245
13,615
Total ..................................................................................................................................................................
400,000
133,333
Request for Comments
rmajette on PRODPC74 with NOTICES
In accordance with the above cited
legislation, comments on the AHRQ
information collection proposal are
requested with regard to any of the
following: (a) Whether the proposed
collection of information is necessary
for the proper performance of functions
of AHRQ, including whether the
information will have practical utility;
(b) the accuracy of AHRQ’s estimate of
burden (including hours and costs) of
the proposed collection of information;
(c) ways to enhance the quality, utility,
and clarity on the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the request for OMB
approval of the proposed information
collection. All comments will become a
matter of public record.
Dated: January 16, 2009.
Carolyn M. Clancy,
Director.
[FR Doc. E9–1751 Filed 1–28–09; 8:45 am]
BILLING CODE 4160–90–M
VerDate Nov<24>2008
15:25 Jan 28, 2009
Jkt 217001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
Title: Protection and Advocacy (P&A)
Voting Access Application and Annual
Report.
OMB No.: 0970–0326.
Description: This is a revision to
include the application for the
previously cleared Help America Vote
Act (HAVA) Annual report.
An application is required by Federal
statute (the Help America Vote Act
(HAVA) of 2002, Pub. L. 107–252,
Section 291, Payments for Protection
and Advocacy Systems, 42 U.S.C.
15461). Each State Protection &
Advocacy (P&A) System must prepare
an application in accordance with the
program announcement.
There is no application kit; the P&As
application may be in the format of its
choice. It must, however, be signed by
the P&As Executive Director or the
designated representative, and contain
the assurances as outlined under Part I.
C. Use of Funds. The P&As designated
representatives may signify their
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
agreement with the conditions/
assurances by signing and returning the
assurance document Attachment B,
found in Part IV of this Instruction. The
assurance document signed by the
Executive Director of the P&A, or other
designated person, should be submitted
with the application to the
Administration on Developmental
Disabilities.
An annual report is required by
Federal statute (the Help America Vote
Act (HAVA) of 2002, Pub. L. 107–252,
Section 291, Payments for Protection
and Advocacy Systems, 42 U.S.C.
15461). Each State Protection &
Advocacy (P&A) System must prepare
and submit an annual report at the end
of every fiscal year. The report
addresses the activities conducted with
the funds provided during the year. The
information from the annual report will
be aggregated into an annual profile of
how HAVA funds have been spent. The
report will also provide an overview of
the P&A goals and accomplishments
and permit the Administration on
Developmental Disabilities to track
progress to monitor grant activities.
Respondents: Protection & Advocacy
Systems—All States, the District of
Columbia, Puerto Rico, the U.S. Virgin
Islands, American Samoa, and Guam.
E:\FR\FM\29JAN1.SGM
29JAN1
5165
Federal Register / Vol. 74, No. 18 / Thursday, January 29, 2009 / Notices
ANNUAL BURDEN ESTIMATES
Number of
respondents
Instrument
Protection and Advocacy (P&A) Voting Access Application ...........................
Protection and Advocacy (P&A) Voting Access Annual Report ......................
Estimated Total Annual Burden
Hours: 1,980.
Additional Information: Copies of the
proposed collection may be obtained by
writing to the Administration for
Children and Families, Office of
Administration, Office of Information
Services, 370 L’Enfant Promenade, SW.,
Washington, DC 20447, Attn: ACF
Reports Clearance Officer. All requests
should be identified by the title of the
information collection. E-mail address:
infocollection@acf.hhs.gov.
OMB Comment: OMB is required to
make a decision concerning the
collection of information between 30
and 60 days after publication of this
document in the Federal Register .
Therefore, a comment is best assured of
having its full effect if OMB receives it
within 30 days of publication. Written
comments and recommendations for the
proposed information collection should
be sent directly to the following: Office
of Management and Budget, Paperwork
Reduction Project, Fax: 202–395–6974,
Attn: Desk Officer for the
Administration for Children and
Families.
Dated: January 26, 2009.
Janean Chambers,
Reports Clearance Officer.
[FR Doc. E9–1925 Filed 1–28–09; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–N–0664]
Arthritis Advisory Committee; Notice
of Meeting
AGENCY:
Food and Drug Administration,
HHS.
rmajette on PRODPC74 with NOTICES
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). The meeting will be open to the
public.
Name of Committee: Arthritis
Advisory Committee.
General Function of the Committee:
To provide advice and
VerDate Nov<24>2008
15:25 Jan 28, 2009
Jkt 217001
55
55
recommendations to the agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on March 5, 2009, from 8:30 a.m.
to 4:00 p.m.
Location: Hilton Washington DC/
Silver Spring, The Ballrooms, 8727
Colesville Rd., Silver Spring, MD. The
hotel telephone number is 301–589–
5200.
Contact Person: Nicole Vesely, Center
for Drug Evaluation and Research (HFD–
21), Food and Drug Administration,
5600 Fishers Lane (for express delivery,
5630 Fishers Lane, rm. 1093), Rockville,
MD 20857, 301–827–6793, fax: 301–
827–6776, e-mail:
nicole.vesely@fda.hhs.gov, or FDA
Advisory Committee Information Line,
1–800–741–8138 (301–443–0572 in the
Washington, DC area), code
3014512532. Please call the Information
Line for up-to-date information on this
meeting. A notice in the Federal
Register about last minute modifications
that impact a previously announced
advisory committee meeting cannot
always be published quickly enough to
provide timely notice. Therefore, you
should always check the agency’s Web
site and call the appropriate committee
hot line/phone line to learn about
possible modifications before coming to
the meeting.
Agenda: The committee will discuss
biologics license application (BLA)
125293, pegloticase, Savient
Pharmaceuticals, Inc., as a therapy for
patients with treatment failure gout.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/ohrms/
dockets/ac/acmenu.htm, click on the
year 2009 and scroll down to the
appropriate advisory committee link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden hours
per response
1
1
20
16
Total burden
hours
1,100
880
person on or before February 19, 2009.
Oral presentations from the public will
be scheduled between approximately 1
p.m. to 2 p.m. Those desiring to make
formal oral presentations should notify
the contact person and submit a brief
statement of the general nature of the
evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or February 10, 2009. Time allotted for
each presentation may be limited. If the
number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by February 11, 2009.
Persons attending FDA’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Nicole
Vesely at least 7 days in advance of the
meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/oc/advisory/
default.htm for procedures on public
conduct during advisory committee
meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C.app. 2).
Dated: January 21, 2009.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E9–1820 Filed 1–28–09; 8:45 am]
BILLING CODE 4160–01–S
E:\FR\FM\29JAN1.SGM
29JAN1
]]>Agencies
[Federal Register Volume 74, Number 18 (Thursday, January 29, 2009)]
[Notices]
[Pages 5164-5165]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-1925]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Submission for OMB Review; Comment Request
Title: Protection and Advocacy (P&A) Voting Access Application and
Annual Report.
OMB No.: 0970-0326.
Description: This is a revision to include the application for the
previously cleared Help America Vote Act (HAVA) Annual report.
An application is required by Federal statute (the Help America
Vote Act (HAVA) of 2002, Pub. L. 107-252, Section 291, Payments for
Protection and Advocacy Systems, 42 U.S.C. 15461). Each State
Protection & Advocacy (P&A) System must prepare an application in
accordance with the program announcement.
There is no application kit; the P&As application may be in the
format of its choice. It must, however, be signed by the P&As Executive
Director or the designated representative, and contain the assurances
as outlined under Part I. C. Use of Funds. The P&As designated
representatives may signify their agreement with the conditions/
assurances by signing and returning the assurance document Attachment
B, found in Part IV of this Instruction. The assurance document signed
by the Executive Director of the P&A, or other designated person,
should be submitted with the application to the Administration on
Developmental Disabilities.
An annual report is required by Federal statute (the Help America
Vote Act (HAVA) of 2002, Pub. L. 107-252, Section 291, Payments for
Protection and Advocacy Systems, 42 U.S.C. 15461). Each State
Protection & Advocacy (P&A) System must prepare and submit an annual
report at the end of every fiscal year. The report addresses the
activities conducted with the funds provided during the year. The
information from the annual report will be aggregated into an annual
profile of how HAVA funds have been spent. The report will also provide
an overview of the P&A goals and accomplishments and permit the
Administration on Developmental Disabilities to track progress to
monitor grant activities.
Respondents: Protection & Advocacy Systems--All States, the
District of Columbia, Puerto Rico, the U.S. Virgin Islands, American
Samoa, and Guam.
[[Page 5165]]
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Number of Average
Instrument Number of responses per burden hours Total burden
respondents respondent per response hours
----------------------------------------------------------------------------------------------------------------
Protection and Advocacy (P&A) Voting Access 55 1 20 1,100
Application....................................
Protection and Advocacy (P&A) Voting Access 55 1 16 880
Annual Report..................................
----------------------------------------------------------------------------------------------------------------
Estimated Total Annual Burden Hours: 1,980.
Additional Information: Copies of the proposed collection may be
obtained by writing to the Administration for Children and Families,
Office of Administration, Office of Information Services, 370 L'Enfant
Promenade, SW., Washington, DC 20447, Attn: ACF Reports Clearance
Officer. All requests should be identified by the title of the
information collection. E-mail address: infocollection@acf.hhs.gov.
OMB Comment: OMB is required to make a decision concerning the
collection of information between 30 and 60 days after publication of
this document in the Federal Register . Therefore, a comment is best
assured of having its full effect if OMB receives it within 30 days of
publication. Written comments and recommendations for the proposed
information collection should be sent directly to the following: Office
of Management and Budget, Paperwork Reduction Project, Fax: 202-395-
6974, Attn: Desk Officer for the Administration for Children and
Families.
Dated: January 26, 2009.
Janean Chambers,
Reports Clearance Officer.
[FR Doc. E9-1925 Filed 1-28-09; 8:45 am]
BILLING CODE 4184-01-P
